Cargando…

Can pyroptosis be a new target in rheumatoid arthritis treatment?

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease of undefined etiology, with persistent synovial inflammation and destruction of articular cartilage and bone. Current clinical drugs for RA mainly include non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, disease modif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Dengqiang, Li, Yujie, Xu, Ranxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324035/ https://www.ncbi.nlm.nih.gov/pubmed/37426634 http://dx.doi.org/10.3389/fimmu.2023.1155606

Ejemplares similares

Pyroptosis, a New Breakthrough in Cancer Treatment
por: Wu, Dengqiang, et al.
Publicado: (2021)

SFRP1 Negatively Modulates Pyroptosis of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis: A Review
por: Jiang, Ping, et al.
Publicado: (2022)

Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
por: Zhao, Jianan, et al.
Publicado: (2021)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

Ferroptosis as an emerging target in rheumatoid arthritis
por: Zhao, Hui, et al.
Publicado: (2023)

New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology
por: Sandhu, Gurvisha, et al.
Publicado: (2022)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2022)

Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment
por: Wu, Di, et al.
Publicado: (2022)

A Novel Drug Combination of Mangiferin and Cinnamic Acid Alleviates Rheumatoid Arthritis by Inhibiting TLR4/NFκB/NLRP3 Activation-Induced Pyroptosis
por: Li, Weijie, et al.
Publicado: (2022)

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
por: Murayama, Masanori A., et al.
Publicado: (2023)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
por: Balendran, Thivya, et al.
Publicado: (2023)

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
por: Diller, Magnus, et al.
Publicado: (2019)

Bioactive Molecules against Rheumatoid Arthritis by Suppressing Pyroptosis
por: Zhou, Qian, et al.
Publicado: (2023)

T-Follicular Regulatory Cells: Potential Therapeutic Targets in Rheumatoid Arthritis
por: Ding, Tingting, et al.
Publicado: (2019)

Toward Overcoming Treatment Failure in Rheumatoid Arthritis
por: Wang, Zhuqian, et al.
Publicado: (2021)

DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
por: Zhao, Jianan, et al.
Publicado: (2022)

B Cells in Rheumatoid Arthritis：Pathogenic Mechanisms and Treatment Prospects
por: Wu, Fengping, et al.
Publicado: (2021)

Natural medicines of targeted rheumatoid arthritis and its action mechanism
por: Liu, Xueling, et al.
Publicado: (2022)

Sustained Drug Treatment Alters the Gut Microbiota in Rheumatoid Arthritis
por: Mei, Liyan, et al.
Publicado: (2021)

Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023)

Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis
por: Li, Ruo-Lan, et al.
Publicado: (2022)

Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis
por: Fan, Siyuan, et al.
Publicado: (2023)

Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
por: Clayton, Sally A., et al.
Publicado: (2021)

Metabolomics in rheumatoid arthritis: Advances and review
por: Xu, Lingxia, et al.
Publicado: (2022)

Significance of pyroptosis-related gene in the diagnosis and classification of rheumatoid arthritis
por: Li, Jian, et al.
Publicado: (2023)

Reestablish immune tolerance in rheumatoid arthritis
por: Shuai, Ziqiang, et al.
Publicado: (2022)

Quercetin is a Potential Therapy for Rheumatoid Arthritis via Targeting Caspase-8 Through Ferroptosis and Pyroptosis
por: Zheng, Qingcong, et al.
Publicado: (2023)

Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022)

Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome
por: Tan, Yuan, et al.
Publicado: (2023)

Identifying the hub genes and immune infiltration related to pyroptosis in rheumatoid arthritis
por: Xie, Wei, et al.
Publicado: (2021)

Ontology and Function of Fibroblast-Like and Macrophage-Like Synoviocytes: How Do They Talk to Each Other and Can They Be Targeted for Rheumatoid Arthritis Therapy?
por: Tu, Jiajie, et al.
Publicado: (2018)

Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs
por: Jing, Weiyao, et al.
Publicado: (2023)

Fibroblast-Like Synoviocytes Glucose Metabolism as a Therapeutic Target in Rheumatoid Arthritis
por: de Oliveira, Patricia Gnieslaw, et al.
Publicado: (2019)

T Cell Migration in Rheumatoid Arthritis
por: Mellado, Mario, et al.
Publicado: (2015)

N(6) -Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review
por: Wu, Sha, et al.
Publicado: (2021)

Cartilage Oligomeric Matrix Protein Induced Arthritis—A New Model for Rheumatoid Arthritis in the C57BL/6 Mouse
por: Zhao, Yunjuan, et al.
Publicado: (2021)

LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
por: Wu, Han, et al.
Publicado: (2021)

Epigenetic Regulation in the Pathogenesis of Rheumatoid Arthritis
por: Yang, Chao, et al.
Publicado: (2022)

Nutrients and rheumatoid arthritis: From the perspective of neutrophils
por: Shao, Ya-Ru, et al.
Publicado: (2023)

CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis
por: Myngbay, Askhat, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ia73lkpgplsqqbn1rbes1dm7e